175 related articles for article (PubMed ID: 35507186)
1. Designing Genetically Engineered Mouse Models (GEMMs) Using CRISPR Mediated Genome Editing.
Desjardins J; Cowan M; Yamanaka Y
Methods Mol Biol; 2022; 2429():515-531. PubMed ID: 35507186
[TBL] [Abstract][Full Text] [Related]
2. Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.
Katigbak A; Robert F; Paquet M; Pelletier J
G3 (Bethesda); 2018 May; 8(5):1627-1635. PubMed ID: 29519936
[TBL] [Abstract][Full Text] [Related]
3. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
4. Genotyping Protocols for Genetically Engineered Mice.
Limaye A; Cho K; Hall B; Khillan JS; Kulkarni AB
Curr Protoc; 2023 Nov; 3(11):e929. PubMed ID: 37984376
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing in Mouse Zygotes and Embryonic Stem Cells by Introducing SgRNA/Cas9 Expressing Plasmids.
Noda T; Oji A; Ikawa M
Methods Mol Biol; 2017; 1630():67-80. PubMed ID: 28643250
[TBL] [Abstract][Full Text] [Related]
6. Targeted Mutations in the Mouse via Embryonic Stem Cells.
Gertsenstein M; Mianné J; Teboul L; Nutter LMJ
Methods Mol Biol; 2020; 2066():59-82. PubMed ID: 31512207
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing in Mice.
Hansen LA; Füchtbauer EM
Methods Mol Biol; 2019; 1961():249-254. PubMed ID: 30912050
[TBL] [Abstract][Full Text] [Related]
8. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.
Wefers B; Wurst W; Kühn R
Methods Mol Biol; 2023; 2631():207-230. PubMed ID: 36995669
[TBL] [Abstract][Full Text] [Related]
10. Modern Approaches to Mouse Genome Editing Using the CRISPR-Cas Toolbox and Their Applications in Functional Genomics and Translational Research.
Monteiro CJ; Heery DM; Whitchurch JB
Adv Exp Med Biol; 2023; 1429():13-40. PubMed ID: 37486514
[TBL] [Abstract][Full Text] [Related]
11. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
12. Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems.
Wu H; Liu Q; Shi H; Xie J; Zhang Q; Ouyang Z; Li N; Yang Y; Liu Z; Zhao Y; Lai C; Ruan D; Peng J; Ge W; Chen F; Fan N; Jin Q; Liang Y; Lan T; Yang X; Wang X; Lei Z; Doevendans PA; Sluijter JPG; Wang K; Li X; Lai L
Cell Mol Life Sci; 2018 Oct; 75(19):3593-3607. PubMed ID: 29637228
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-mediated genome editing and guide RNA design.
Wiles MV; Qin W; Cheng AW; Wang H
Mamm Genome; 2015 Oct; 26(9-10):501-10. PubMed ID: 25991564
[TBL] [Abstract][Full Text] [Related]
15. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
16. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
17. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
18. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
[TBL] [Abstract][Full Text] [Related]
19. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
[TBL] [Abstract][Full Text] [Related]
20. A non-inheritable maternal Cas9-based multiple-gene editing system in mice.
Sakurai T; Kamiyoshi A; Kawate H; Mori C; Watanabe S; Tanaka M; Uetake R; Sato M; Shindo T
Sci Rep; 2016 Jan; 6():20011. PubMed ID: 26817415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
